Pretreatment neutrophil-to-lymphocyte ratio (NLR) has been reported to be associated with
the prognosis of inoperable gastric cancer patients with systemic therapy. However, no …

Background Although the prognostic value of the neutrophil to lymphocyte ratio (NLR) in
gastric cancer (GC) patients has been investigated by many studies, the results are …

The prognostic role of neutrophil to lymphocyte ratio (NLR) in gastric cancer remains
controversial. We aimed to quantify the prognostic role of peripheral blood NLR in gastric …

Background Several studies have shown that the neutrophil to lymphocyte ratio (NLR) in
peripheral blood is a prognostic factor of various cancers. However, there is limited …

Background Gastric cancer (GC) remains an important global health concern with limited
treatment options for advanced cases. Immunotherapy has shown promising results, but …

Aim The role of neutrophil–lymphocyte ratio (NLR) and derived neutrophil–lymphocyte ratio
(d-NLR) in outcome prediction is assessed in patients with advanced gastric cancer …

Background The prognostic role of inflammation indices, such as the neutrophil-to-
lymphocyte ratio (NLR) in gastric cancer (GC) remains controversial. We conducted a meta …

Background Several studies have shown that neutrophil lymphocyte ratio (NLR) may be
associated with the prognosis of gastric cancer (GC), but the results are controversial …

Purpose: The neutrophil-to-lymphocyte ratio (NLR) is an accessible marker from a routine
blood test. This study explored the prognostic and predictive value of a change in NLR (c …

Background The neutrophil to lymphocyte ratio (NLR) is a cost-effective and easily
identifiable inflammatory biomarker that has been shown to be closely associated with tumor …